Nausea and vomiting after dexamethasone versus droperidol following outpatient laparoscopy with a propofol-based general anesthetic

被引:20
作者
Rothenberg, DM [1 ]
McCarthy, RJ [1 ]
Peng, CC [1 ]
Normoyle, DA [1 ]
机构
[1] Rush Presbyterian St Lukes Med Ctr, Dept Anesthesiol, Rush Med Coll, Chicago, IL 60612 USA
关键词
dexamethasone; droperidol; postoperative nausea and vomiting; ambulatory surgery;
D O I
10.1111/j.1399-6576.1998.tb05294.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: The purpose of this randomized, double-blinded study was to compare the incidence and severity of postoperative nausea and vomiting (PONV) after dexamethasone versus droperidol following gynecologic laparoscopy, a group at high risk for developing PONV. Methods: Ninety-five patients who underwent a propofol-based general anesthetic received either dexamethasone 0.17 mg/kg IV or droperidol 0.02 mg/kg IV, just prior to abdominal incision. Nausea, retching, vomiting, degree of sedation, and discharge times were assessed in the Post Anesthesia Care Unit (PACU), and the Ambulatory Care Unit (ACU). Following hospital discharge (24 h), the patients were contacted by telephone to assess any further complications. Results: PONV in the PACU (14.6% vs. 14.9%) and ACU (8.3% vs. 14.9%) was as common after dexamethasone as after droperidol. PONV following hospital discharge was, however, less common after dexamethasone than after droperidol (4.2% vs. 17.0%, P=0.041). Postoperatively, no complications of therapy were detected. Conclusions: We conclude that PONV is similar with dexamethasone and droperidol, but dexamethasone may have a longer duration of action in patients undergoing gynecologic laparoscopy. (C) Acta Anatesthesiologica Scandinavica 42 (1998).
引用
收藏
页码:637 / 642
页数:6
相关论文
共 32 条
[1]   DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].
AAPRO, MS ;
PLEZIA, PM ;
ALBERTS, DS ;
GRAHAM, V ;
JONES, SE ;
SURWIT, EA ;
MOON, TE .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471
[2]  
April MM, 1996, ARCH OTOLARYNGOL, V122, P117
[3]   CATARACTS INDUCED BY INTERMITTENT DECADRON USED AS AN ANTIEMETIC [J].
BLUMING, AZ ;
ZEEGEN, P .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :221-223
[4]   THE PHARMACOKINETICS OF SINGLE HIGH-DOSES OF DEXAMETHASONE IN CANCER-PATIENTS [J].
BRADY, ME ;
SARTIANO, GP ;
ROSENBLUM, SL ;
ZAGLAMA, NE ;
BAUGUESS, CT .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (06) :593-596
[5]   POSTOPERATIVE NAUSEA AND VOMITING AFTER-DISCHARGE FROM OUTPATIENT SURGERY CENTERS [J].
CARROLL, NV ;
MIEDERHOFF, P ;
COX, FM ;
HIRSCH, JD .
ANESTHESIA AND ANALGESIA, 1995, 80 (05) :903-909
[6]   ANTI-EMETIC EFFICACY OF DEXAMETHASONE THERAPY IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].
CASSILETH, PA ;
LUSK, EJ ;
TORRI, S ;
DINUBILE, N ;
GERSON, SL .
ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (07) :1347-1349
[7]  
COHEN J, 1988, STAT POWER ANAL BEHA, P215
[8]  
DRAPKIN RL, 1982, P AM SOC CLIN ONCOL, V1, pA61
[9]  
FISCHLER M, 1986, ANESTHESIOLOGY, V64, P486
[10]   NAUSEA IN CANCER-CHEMOTHERAPY IS INVERSELY RELATED TO URINARY CORTISOL EXCRETION [J].
FREDRIKSON, M ;
HURSTI, T ;
FURST, CJ ;
STEINECK, G ;
BORJESON, S ;
WIKBLOM, M ;
PETERSON, C .
BRITISH JOURNAL OF CANCER, 1992, 65 (05) :779-780